Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Richter transformation in Chronic Lymphocytic Leukemia.
Innocenti I, Benintende G, Tomasso A, Fresa A, Autore F, Larocca LM, Laurenti L. Innocenti I, et al. Among authors: benintende g. Hematol Oncol. 2023 Aug;41(3):293-300. doi: 10.1002/hon.3106. Epub 2022 Nov 30. Hematol Oncol. 2023. PMID: 36433773 Review.
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021.
Bacigalupo A, Innocenti I, Rossi E, Sora F, Galli E, Autore F, Metafuni E, Chiusolo P, Giammarco S, Laurenti L, Benintende G, Sica S, De Stefano V. Bacigalupo A, et al. Among authors: benintende g. Front Immunol. 2021 May 4;12:637512. doi: 10.3389/fimmu.2021.637512. eCollection 2021. Front Immunol. 2021. PMID: 34017327 Free PMC article. Review.
VEGF and IL-6 Correlation in POEMS: a Potential Upcoming Marker of Active Disease and Early Autologous BMT Response.
Tomasso A, Innocenti I, Autore F, Fresa A, Benintende G, Vuono F, Baroni S, Giannotta C, Chiusolo P, Sorà F, Sica S, Laurenti L. Tomasso A, et al. Among authors: benintende g. Mediterr J Hematol Infect Dis. 2022 Jan 1;14(1):e2022007. doi: 10.4084/MJHID.2022.007. eCollection 2022. Mediterr J Hematol Infect Dis. 2022. PMID: 35070214 Free PMC article. No abstract available.
Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid-19 pandemics.
Innocenti I, Tomasso A, Benintende G, Autore F, Fresa A, Vuono F, Stirparo L, Galli E, D'Arena G, Sorà F, Efremov D, Laurenti L. Innocenti I, et al. Among authors: benintende g. Hematol Oncol. 2022 Aug;40(3):469-474. doi: 10.1002/hon.2966. Epub 2022 Feb 2. Hematol Oncol. 2022. PMID: 35076123 Free PMC article.
Measurable residual disease in chronic lymphocytic leukemia.
Benintende G, Pozzo F, Innocenti I, Autore F, Fresa A, D'Arena G, Gattei V, Lurenti L. Benintende G, et al. Front Oncol. 2023 Feb 14;13:1112616. doi: 10.3389/fonc.2023.1112616. eCollection 2023. Front Oncol. 2023. PMID: 36865804 Free PMC article. Review.
Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience.
Innocenti I, Fresa A, Tomasso A, Tarnani M, De Padua L, Benintende G, Pasquale R, Galli E, Morelli F, Giannarelli D, Autore F, Laurenti L. Innocenti I, et al. Among authors: benintende g. Cancers (Basel). 2023 Nov 26;15(23):5592. doi: 10.3390/cancers15235592. Cancers (Basel). 2023. PMID: 38067296 Free PMC article.
39 results